Allergy and Immunology
The fields of allergy and immunology are rapidly evolving with breakthroughs in targeted biologics, immunomodulators, and desensitization therapies. Companies are advancing new treatments for allergic diseases, atopic conditions, and immune dysregulation by leveraging deep immunological insights. These innovations are helping patients achieve long-term relief, improved quality of life, and in some cases, disease modification.
Key Focus Areas:
Biologic Therapies for Allergic and Atopic Diseases
Targeting IgE, IL-4, IL-5, IL-13, and IL-31 to reduce inflammation and hypersensitivity in asthma, atopic dermatitis, and chronic urticaria.Allergen-Specific Immunotherapy (AIT)
Sublingual (SLIT), subcutaneous (SCIT), and epicutaneous desensitization platforms for treating food, environmental, and venom allergies.Monoclonal Antibodies for Severe Asthma & Eosinophilic Conditions
Anti-IL-5, anti-IL-5R, anti-IL-13, and anti-TSLP antibodies reducing eosinophil-driven inflammation in asthma and EGIDs.Novel Cytokine and Receptor Blockers
Targeting Th2 cytokines and their receptors to rebalance immune signaling in allergic diseases.Peanut & Food Allergy Therapies
Standardized oral immunotherapy (OIT), biologics, and next-generation antigen-specific desensitization platforms.Immune Tolerance Induction
Therapeutic strategies aimed at retraining the immune system to stop recognizing allergens as threats.JAK Inhibitors for Atopic Dermatitis
Oral and topical agents targeting JAK1/2 to suppress cytokine signaling involved in skin inflammation.Microbiome Modulation in Allergy
Investigational approaches restoring microbial balance to prevent or treat allergic conditions, particularly in early childhood.Mast Cell & Basophil Stabilization
Small molecules and antibodies to block histamine release and allergic mediator activity.Biomarker-Based Stratification
Identification of endotypes and predictive biomarkers to tailor therapies in asthma and chronic rhinosinusitis.Others